- Memorial Sloan-Kettering Physician-Scientists Present Significant Clinical Cancer Research Advances at ASCO Annual MeetingIn an extraordinary demonstration of excellence, five Memorial Sloan-Kettering physician-scientists were selected to participate in the press program at the 2011 American Society of Clinical Oncology annual meeting, held June 3-7 in Chicago.
- Cancer Survivorship: An Interview with Mary McCabeIn 2003, Mary McCabe was recruited to lead Memorial Sloan-Kettering Cancer Center's Cancer Survivorship Initiative and since that time has worked to develop a comprehensive program for cancer survivors, which includes follow-up care, research, and education and training.
- The Campaign for Memorial Sloan-Kettering ExtendedIn a move designed to position the Center to meet its most pressing future needs, the Boards of Overseers and Managers have authorized a five-year extension of the Campaign for Memorial Sloan-Kettering and raised the overall goal to $3.5 billion.
- Memorial Sloan-Kettering Program Cultivates the Healing Power of the PenMemorial Sloan-Kettering's Visible Ink writing program helps participants restore a sense of stability to their lives through the creative expression of their thoughts, feelings, hopes, and fears.
- Study Leads to New Recommendations for Surgical Treatment of Breast CancerA multicenter study has found that for women who meet certain criteria -- about 20 percent of all breast cancer patients -- the surgery, called axillary node dissection, is unnecessary and does not improve survival or reduce rates of recurrence.
- Studies Provide New Insight into Fundamental Biological ProcessDevelopmental biologist Maria Jasin studies homologous recombination, which is important in DNA repair and can lead to cancer when it malfunctions.
- Immunotherapy Drug Receives FDA Approval for Advanced MelanomaThe US Food and Drug Administration announced in late March that the drug ipilimumab (Yervoy™) had been approved for the treatment of patients with metastatic melanoma.
- CancerSmart Lecture Highlights the "New" Biology of Breast CancerAn audience of more than 300 gathered in Memorial Sloan-Kettering's Rockefeller Research Laboratories Auditorium in March to hear Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs, discuss "The 'New' Biology of Breast Cancer and What It Means to You."
- Memorial Sloan-Kettering Researchers Discover How Prostate Cancer Disease Pathways Regulate Each OtherMemorial Sloan-Kettering researchers have discovered that the AR and PI3K disease pathways regulate each other through reciprocal negative feedback.
- New Tool to Predict Breast Cancer MetastasisMemorial Sloan-Kettering Cancer Center researchers have identified a feature in the DNA of breast cancer cells that might indicate the likelihood a woman's disease will become life threatening.
- Charles Sawyers Receives Korsmeyer AwardCharles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, is a co-recipient of the 2011 Stanley J. Korsmeyer Award from the American Society for Clinical Investigation.
- Francesca Gany is Chief of New Immigrant Health ServiceFrancesca M. Gany has joined Memorial Sloan-Kettering as Chief of the newly formed Immigrant Health and Cancer Disparities Service.
- Melissa Pessin Named Chair of Laboratory MedicineMelissa S. Pessin has joined Memorial Sloan-Kettering Cancer Center as an attending physician and Chair of the Department of Laboratory Medicine.
Inside MSKCC
|
©2012 Memorial Sloan-Kettering Cancer Center